New York, NY -- Learn from the experts about new developments in the field of rheumatoid arthritis (RA) research. Top scientists from the Harvard, Cornell, University of Dublin and University of Colorado will discuss the role of the IL-1 cytokine in the RA disease process, impact of bone degradation, discovery of gene markers for RA severity and patient’s perspective on treatment and quality of life.
A New Age in Rheumatoid Arthritis:
A Science Writer's Roundtable
Thursday, Oct. 12, 2000
8:30 a.m. Continental Breakfast
9 a.m. Media Roundtable
The New York Academy of Sciences
2 East 63rd Street
New York, NY
RSVP by Oct. 10 to:
Elisia Greiner, 212-601-8083
Shareese Thompson, 212-601-8246
Agenda:
A New Age in RA
William P. arend, M.D.
University of Colorado Health Sciences Center
The Molecular Biology of IL-1 and Its Role in the Pathogenesis of RA
Charles A. Dinarello, M.D.
University of Colorado Health Sciences Center
Bone Degradation: The New Target in RA Treatment
Ellen M. Gravallese, M.D.
Harvard Medical School
Joint Destruction: The Hidden Effects of RA
Barry Bresnihan, M.D., F.R.C.P.
University College of Dublin
Living With RA: The Patient's Perspective on Treatment and Quality of Life
Melanie J. Harrison, M.D., M.S.
Cornell University Medical College